In this study, we compared the osteoclastic capacity of CD14+CD16+ and CD14+CD16− monocytes in RA and determined the expression levels as well as the potential involvement of Tyro3TK in their osteoclastogenesis, aiming to further understand the mechanism of RA bone destruction. This evidence concerns the gene CD14 and rheumatoid arthritis.